AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting
9/5 16:07
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatAbbVie (NYSE:ABBV) told shareholders at its annual meeting that 2025 was “another excellent year” for the company, citing record sales, stronger-than-expected revenue and continued investment in its dru...